{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T01:31:00Z","timestamp":1784165460179,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,9]],"date-time":"2015-10-09T00:00:00Z","timestamp":1444348800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13063-015-0973-x","type":"journal-article","created":{"date-parts":[[2015,10,9]],"date-time":"2015-10-09T14:11:25Z","timestamp":1444399885000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Early oral switch therapy in low-risk Staphylococcus aureus bloodstream infection (SABATO): study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"16","author":[{"name":"for the SABATO trial group (with linked authorship to the individuals in the Acknowledgements section)","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achim J.","family":"Kaasch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"F\u00e4tkenheuer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhild","family":"Prinz-Langenohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Paulus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hellmich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Wei\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norma","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siegbert","family":"Rieg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried V.","family":"Kern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,9]]},"reference":[{"key":"973_CR1","unstructured":"WHO Global Strategy for Containment of Antimicrobial Resistance. World Health Organization;Geneva, 2001."},{"key":"973_CR2","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/QCO.0b013e32833bcc8a","volume":"23","author":"WV Kern","year":"2010","unstructured":"Kern WV. Management of Staphylococcus aureus bacteremia and endocarditis: progresses and challenges. Curr Opin Infect Dis. 2010;23:346\u201358.","journal-title":"Curr Opin Infect Dis"},{"key":"973_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1001\/archinte.162.1.25","volume":"162","author":"AG Jensen","year":"2002","unstructured":"Jensen AG, Wachmann CH, Espersen F, Scheibel J, Skinhoj P, Frimodt-Moller N. Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases. Arch Intern Med. 2002;162:25\u201332.","journal-title":"Arch Intern Med"},{"key":"973_CR4","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jinf.2009.03.011","volume":"58","author":"TM Walker","year":"2009","unstructured":"Walker TM, Bowler IC, Bejon P. Risk factors for recurrence after Staphylococcus aureus bacteraemia. A retrospective matched case\u2013control study. J Infect. 2009;58:411\u20136.","journal-title":"J Infect"},{"key":"973_CR5","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jinf.2011.03.003","volume":"62","author":"H Asgeirsson","year":"2011","unstructured":"Asgeirsson H, Kristjansson M, Kristinsson KG, Gudlaugsson O. Staphylococcus aureus bacteraemia - nationwide assessment of treatment adequacy and outcome. J Infect. 2011;62:339\u201346.","journal-title":"J Infect"},{"key":"973_CR6","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/jac\/dkl017","volume":"57","author":"CG Gemmell","year":"2006","unstructured":"Gemmell CG, Edwards DI, Fraise AP, Gould FK, Ridgway GL, Warren RE. Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. J Antimicrob Chemother. 2006;57:589\u2013608.","journal-title":"J Antimicrob Chemother"},{"key":"973_CR7","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1093\/cid\/ciq146","volume":"52","author":"C Liu","year":"2011","unstructured":"Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52:e18\u201355.","journal-title":"Clin Infect Dis"},{"key":"973_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/599376","volume":"49","author":"LA Mermel","year":"2009","unstructured":"Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O\u2019Grady NP, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49:1\u201345.","journal-title":"Clin Infect Dis"},{"key":"973_CR9","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1001\/jama.290.19.2588","volume":"290","author":"J Chastre","year":"2003","unstructured":"Chastre J, Wolff M, Fagon JY, Chevret S, Thomas F, Wermert D, et al. Comparison of 8 vs 15\u00a0days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA. 2003;290:2588\u201398.","journal-title":"JAMA"},{"key":"973_CR10","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/j.1445-5994.2004.00601.x","volume":"34","author":"S Briggs","year":"2004","unstructured":"Briggs S, Ellis-Pegler R, Roberts S, Thomas M, Woodhouse A. Short course intravenous benzylpenicillin treatment of adults with meningococcal disease. Intern Med J. 2004;34:383\u20137.","journal-title":"Intern Med J"},{"key":"973_CR11","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1586\/14787210.5.3.507","volume":"5","author":"M Aoun","year":"2007","unstructured":"Aoun M. Empiric therapy for febrile neutropenia: what are the choices? Expert Rev Anti Infect Ther. 2007;5:507\u201315.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"973_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0002-9343(86)90180-4","volume":"81","author":"JJ Rahal Jr","year":"1986","unstructured":"Rahal Jr JJ, Chan YK, Johnson G. Relationship of staphylococcal tolerance, teichoic acid antibody, and serum bactericidal activity to therapeutic outcome in Staphylococcus aureus bacteremia. Am J Med. 1986;81:43\u201352.","journal-title":"Am J Med"},{"key":"973_CR13","doi-asserted-by":"publisher","first-page":"304","DOI":"10.7326\/0003-4819-119-4-199308150-00010","volume":"119","author":"JA Jernigan","year":"1993","unstructured":"Jernigan JA, Farr BM. Short-course therapy of catheter-related Staphylococcus aureus bacteremia: a meta-analysis. Ann Intern Med. 1993;119:304\u201311.","journal-title":"Ann Intern Med"},{"key":"973_CR14","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1086\/424506","volume":"39","author":"J Schrenzel","year":"2004","unstructured":"Schrenzel J, Harbarth S, Schockmel G, Genne D, Bregenzer T, Flueckiger U, et al. A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection. Clin Infect Dis. 2004;39:1285\u201392.","journal-title":"Clin Infect Dis"},{"key":"973_CR15","doi-asserted-by":"publisher","first-page":"e14170","DOI":"10.1371\/journal.pone.0014170","volume":"5","author":"GE Thwaites","year":"2011","unstructured":"Thwaites GE. The management of Staphylococcus aureus bacteremia in the United Kingdom and Vietnam: a multi-centre evaluation. PLoS One. 2011;5:e14170.","journal-title":"PLoS One"},{"key":"973_CR16","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1055\/s-2008-1046715","volume":"133","author":"H Seifert","year":"2008","unstructured":"Seifert H, Wisplinghoff H, Kaasch A, Achilles K, Langhorst A, Peyerl-Hoffmann G, et al. [Epidemiology, course and prognosis of Staphylococcus aureus bacteremia - Preliminary results from the INSTINCT (INvasive STaphylococcus aureus INfection CohorT) cohort] (German). Dtsch Med Wochenschr. 2008;133:340\u20135.","journal-title":"Dtsch Med Wochenschr"},{"key":"973_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/cid\/cir320","volume":"53","author":"AJ Kaasch","year":"2011","unstructured":"Kaasch AJ, Fowler Jr VG, Rieg S, Peyerl-Hoffmann G, Birkholz H, Hellmich M, et al. Use of a simple criteria set for guiding echocardiography in nosocomial Staphylococcus aureus bacteremia. Clin Infect Dis. 2011;53:1\u20139.","journal-title":"Clin Infect Dis"},{"key":"973_CR18","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s15010-013-0428-9","volume":"41","author":"AJ Kaasch","year":"2013","unstructured":"Kaasch AJ, Rieg S, Kuetscher J, Brodt HR, Widmann T, Herrmann M, et al. Delay in the administration of appropriate antimicrobial therapy in Staphylococcus aureus bloodstream infection: a prospective multicenter hospital-based cohort study. Infection. 2013;41:979\u201385.","journal-title":"Infection"},{"key":"973_CR19","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1001\/jama.295.10.1152","volume":"295","author":"G Piaggio","year":"2006","unstructured":"Piaggio G, Elbourne DR, Altman DG, Pocock SJ, Evans SJ. Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. JAMA. 2006;295:1152\u201360.","journal-title":"JAMA"},{"key":"973_CR20","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s15010-011-0104-x","volume":"39","author":"AJ Kaasch","year":"2011","unstructured":"Kaasch AJ, Rieg S, Neumann S, Seifert H, Kern WV. Measuring mortality in Staphylococcus aureus bloodstream infections: are 3\u00a0months of follow-up enough? Infection. 2011;39:281\u20132.","journal-title":"Infection"},{"key":"973_CR21","doi-asserted-by":"publisher","first-page":"E164","DOI":"10.1111\/j.1469-0691.2012.03851.x","volume":"18","author":"E Bilavsky","year":"2012","unstructured":"Bilavsky E, Lerman Y, Rabinovich A, Salomon J, Lawrence C, Rossini A, et al. Carriage of methicillin-resistant Staphylococcus aureus on admission to European rehabilitation centres--a prospective study. Clin Microbiol Infect. 2012;18:E164\u20139.","journal-title":"Clin Microbiol Infect"},{"key":"973_CR22","doi-asserted-by":"publisher","first-page":"4213","DOI":"10.1128\/JCM.05290-11","volume":"49","author":"M Sangvik","year":"2011","unstructured":"Sangvik M, Olsen RS, Olsen K, Simonsen GS, Furberg AS, Sollid JU. Age- and gender-associated Staphylococcus aureus spa types found among nasal carriers in a general population: the Tromso Staph and Skin Study. J Clin Microbiol. 2011;49:4213\u20138.","journal-title":"J Clin Microbiol"},{"key":"973_CR23","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1086\/313753","volume":"30","author":"JS Li","year":"2000","unstructured":"Li JS, Sexton DJ, Mick N, Nettles R, Fowler Jr VG, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633\u20138.","journal-title":"Clin Infect Dis"},{"key":"973_CR24","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) Version 4.03. National Cancer Institute; 2010. U.S. Department of Health and Human Services. \nhttp:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm\n\n. Accessed date 2015-10-08"},{"key":"973_CR25","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1002\/(SICI)1097-0258(19980930)17:18<2133::AID-SIM901>3.0.CO;2-2","volume":"17","author":"P Bauer","year":"1998","unstructured":"Bauer P, Rohmel J, Maurer W, Hothorn L. Testing strategies in multi-dose experiments including active control. Stat Med. 1998;17:2133\u201346.","journal-title":"Stat Med"},{"key":"973_CR26","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1086\/427806","volume":"40","author":"VG Fowler Jr","year":"2005","unstructured":"Fowler Jr VG, Justice A, Moore C, Benjamin Jr DK, Woods CW, Campbell S, et al. Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia. Clin Infect Dis. 2005;40:695\u2013703.","journal-title":"Clin Infect Dis"},{"key":"973_CR27","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/01.md.0000091184.93122.09","volume":"82","author":"FY Chang","year":"2003","unstructured":"Chang FY, Peacock Jr JE, Musher DM, Triplett P, MacDonald BB, Mylotte JM, et al. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Med (Baltimore). 2003;82:333\u20139.","journal-title":"Med (Baltimore)"},{"key":"973_CR28","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I","volume":"17","author":"RG Newcombe","year":"1998","unstructured":"Newcombe RG. Interval estimation for the difference between independent proportions: comparison of eleven methods. Stat Med. 1998;17:873\u201390.","journal-title":"Stat Med"},{"key":"973_CR29","unstructured":"Guideline on the evaluation of medicinal products indicated for treatment of bacterial infections (CPMP\/EWP\/558\/95 rev 2; 15 December 2011). Committee for Medicinal Products for Human Use (CHMP); 2011. European Medicines Agency. \nhttp:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/09\/WC500003417.pdf\n\n. Accessed date 2015-10-08"},{"key":"973_CR30","unstructured":"Points to consider on switching between superiority and non-inferiority (CPMP\/EWP\/482\/99 rev 2; 27 July 2000). Committee for Medicinal Products for Human Use (CHMP); 2000. European Medicines Agency. \nhttp:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/09\/WC500003658.pdf\n\n. Accessed date 2015-10-08"},{"key":"973_CR31","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1111\/j.0006-341X.1999.01286.x","volume":"55","author":"W Lehmacher","year":"1999","unstructured":"Lehmacher W, Wassmer G. Adaptive sample size calculations in group sequential trials. Biometrics. 1999;55:1286\u201390.","journal-title":"Biometrics"},{"key":"973_CR32","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1097\/00003246-199206000-00025","volume":"20","author":"ACCP\/SCCM Consensus Conference Committee","year":"1992","unstructured":"ACCP\/SCCM Consensus Conference Committee. Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864\u201374.","journal-title":"Crit Care Med"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-015-0973-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-015-0973-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-015-0973-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T21:03:53Z","timestamp":1581455033000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-015-0973-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,9]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["973"],"URL":"https:\/\/doi.org\/10.1186\/s13063-015-0973-x","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,9]]},"assertion":[{"value":"22 December 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"450"}}